2011

1. Carcinoma-derived Interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation

   PLoS ONE, Vol. 6, Núm. 3

2. Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes

   PLoS ONE, Vol. 6, Núm. 12

3. Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients

   Journal of Immunology, Vol. 187, Núm. 11, pp. 6130-6142

4. Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo

   International Journal of Cancer, Vol. 129, Núm. 2, pp. 374-386